Skip to Main content Skip to Navigation
Journal articles

Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2

Abstract : Thrombosis results in heparin-induced thrombocytopenia (HIT) from cellular activation involving Fc receptors. In this study, the FcγRIIA 131RR genotype was found to increase the risk of thrombosis in HIT patients (odds ratio: 5.9; 95% confidence interval: 1.7-20). When platelet aggregation tests (PATs) were performed with platelet-rich plasma (PRP), a shorter lag time was measured in 131RR donors compared to individuals with the HR and HH genotypes in response to HIT plasma or 5B9, a recently developed humanized monoclonal antibody to PF4/heparin. Importantly, this difference was no longer detectable when PATs were performed with washed platelets or immunoglobulin (Ig)G-depleted PRP. Moreover, polyclonal IgG or monoclonal IgG1 added to IgG-depleted PRP increased the lag time in response to 5B9. HH platelets were also sensitive to IgG2, which in contrast, failed to inhibit the response of 131RR platelets to 5B9. Finally, higher tissue factor messenger RNA levels were measured in the whole blood of 131RR donors after activation by HIT antibodies, with increased phospholipid procoagulant activity. These results demonstrate that HIT patients homozygous for the FcγRIIA 131R allele have a higher risk of thrombosis, probably due to increased cell activation by antibodies to PF4/heparin, with a lower inhibitory effect of endogenous IgG, especially from the IgG2 subclass.
Complete list of metadatas

https://hal-univ-tours.archives-ouvertes.fr/hal-02425484
Contributor : Valérie Gouilleux <>
Submitted on : Monday, December 30, 2019 - 3:49:19 PM
Last modification on : Thursday, March 19, 2020 - 12:54:03 PM

Links full text

Identifiers

Collections

Citation

Jérôme Rollin, Claire Pouplard, Hsueh Cheng Sung, Dorothée Leroux, Armand Saada, et al.. Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2. Blood, American Society of Hematology, 2015, 125 (15), pp.2397-2404. ⟨10.1182/blood-2014-09-594515⟩. ⟨hal-02425484⟩

Share

Metrics

Record views

80